View options
Result details

Results per page
Articles per page View Sort by

8 results matched your search query
Keywords = Surgery

  • Open Access Case Report
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2018, 3(2), 96-103. http://doi.org/10.31586/Surgery.0302.06
    20 Views 37 Downloads PDF Full-text (2.387 MB)  HTML Full-text
    Abstract
    Primary cardiac tumors are rare with an incidence ranging from 0.001% to 0.03% in autopsy series. The prognosis of cardiac sarcomas remains poor because it proliferates rapidly, and distant metastases are often found at diagnosis. We present a case of liposarcoma in the atrium of the heart as case report
    [...] Read more.
    Primary cardiac tumors are rare with an incidence ranging from 0.001% to 0.03% in autopsy series. The prognosis of cardiac sarcomas remains poor because it proliferates rapidly, and distant metastases are often found at diagnosis. We present a case of liposarcoma in the atrium of the heart as case report and same time,we do a literature review about it.Case Report: We present the case of a 30-year-old female with a significant tumor of cardiac liposarcoma, with chief complaint of dyspnea, tachycardia and heart failure even angina pectoris.Conclusion: The diagnostician?s differential diagnosis must be broad when encountering common chief complaints, such as tachycardia, heart failure and angina pectoris.  Full article
    Figures

    Figure 2 of 3

    References
    [1]
    Guilherme H. Oliveira, MD*; Sadeer G. Al-Kindi, MD*; Christopher Hoimes, DO; Soon J. Park, MD Characteristics and Survival of Malignant Cardiac Tumors A 40-Year Analysis of >500 Patients (Circulation. 2015;132:2395-2402. DOI: 10.1161/CIRCULATIONAHA.115.016418.)
    [2]
    Cristina Basso, Stefania Rizzo, Marialuisa Valente, Gaetano Thiene, Prevalence and pathology of primary cardiac tumours. Cardiovascular Medicine 2012;15(1):18?29
    [3]
    Vander Salm TJ.Unusual primary tumors of the heart. Semin Thorac Cardiovasc Surg.2000 Apr;12(2):89-100.
    [4]
    Elizabeth S. Ellent, MD,1 Ronald Chong-Yik, MD, MPH,1,2 Abdul Mukhtadir Khan, MD3. Metastatic Cardiac Angiosarcoma in a 26-Year-Old Male. Ochsner Journal 16:324?328, 2016
    [5]
    Freedom RM, Lee KJ, MacDonald C, Taylor G. Selected aspects of cardiac tumors in infancy and childhood. Pediatr Cardiol. 2000;21:299? 316.
    [6]
    Song Y, Hu R, Yao Q. Pathological analysis of 268 cases of tumors in the heart and the pericardium. J SUN Yat-sen-Univ (Med Sci) 2003;24:197? 201.
    [7]
    Roberts WC. Primary and secondary neoplasms of the heart. Am J Cardiol. 1997;80:671?82.
    [8]
    Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastasis. J Clin Pathol. 2007;60:27?34.
    [9]
    Hanfling SM. Metastatic cancer to the heart. Review of the literature and report of 127 cases. Circulation. 1960;22:474?83.
    [10]
    Thomas-de-Montpr?ville V, Nottin R, Dulmet E, Serraf A. Heart tumors in children and adults: clinicopathological study of 59 patients from a surgical center. Cardiovasc Pathol. 2007;16:22?8.
    [11]
    Bussani R, De-Giorgio F, Abbate A, Silvestri F. Cardiac metastasis. J Clin Pathol. 2007;60:27?34.
    [12]
    Travis WT, Brambilla E, Muller-Hermelink HK, Harris CC, eds. Pathology and genetics of tumours of the lung, pleura and heart. World Health Organisation Classification of tumours. Lyon: IARC; 2004.
    [13]
    Reynen K. Cardiac myxomas. N Engl J Med. 1995;33:1610?7.
    [14]
    Basso C, Valente M, Casarotto D, Thiene G. Cardiac lithomyxoma. Am J Cardiol. 1997;80:1249?51.
    [15]
    Burke AP, Virmani R. Cardiac myxoma: a clinicopathologic study. Am J Clin Pathol. 1993;100:671?80.
    [16]
    Edwards FH, Hale D, Cohen A, Thompson L, Pezzella AT, Virmani R. Primary cardiac valve tumors. Ann Thorac Surg. 1991;52:1127?31.
    [17]
    Sun JP, Asher CR, Yang XS, Cheng GG, Scalia GM, Massed AG, et al. Clinical and echocardiographic characteristics of papillary fibroelastomas: a retrospective and prospective study in 162 patients. Circulation. 2001;103:2687?93.
    [18]
    Basso C, Bottio T, Valente M, Bonato R, Casarotto D, Thiene G. Primary cardiac valve tumours. Heart. 2003;89:1259?60.
    [19]
    Gowda RM, Khan IA, Nair CK, Mehta NJ, Vasavada BC, Sacchi TJ. Cardiac papillary fibroelastoma: a comprehensive analysis of 725 cases. Am Heart J. 2003;146:404?10.
    [20]
    Valente M, Basso C, Thiene G, Bressan M, Stritoni P, Cocco P, Fasoli G. Fibroelastic papilloma: a not-so-benign cardiac tumor. Cardiovasc Pathol. 1992;1:161?6.
    [21]
    Cunningham KS, Veinot JP, Feindel CM, Butany J. Fatty lesions of the atria and interatrial septum. Hum Pathol. 2006;37:1245?51.
    [22]
    Brizard C, Latremouille C, Jebara VA, Acar C, Fabiani JN, Carpentier AF. Cardiac hemangiomas. Ann Thorac Surg. 1993;56:390?4.
    [23]
    Kipfer B, Englberger L, Stauffer E, Carrel T. Rare presentation of cardiac hemangiomas. Ann Thorac Surg. 2000;70:977?9.
    [24]
    Uzun O, Wilson DG, Vujanic GM, Parsons JM, De Giovanni JV. Cardiac tumours in children. Orphanet J Rare Dis. 2007;2:11.
    [25]
    Chan HSL, Sonley MJ, Moes CAF, Daneman A, Smith CR, Martin DJ. Primary and secondary tumors of childhood involving the heart, pericardium and great vessels. A report of 75 cases and review of the literature. Cancer. 1985;56:825?36.
    [26]
    Beghetti M, Gow RM, Haney I, Maswon J, Williams WG, Freedom RM. Pediatric primary benign cardiac tumors: a 15-year review. Am Heart J. 1997;134:1107?14.
    [27]
    Becker, Anton E. Primary heart tumors in the pediatric age group: a review of salient pathologic features relevant for clinicians. Pediatr Cardiol. 2000;21:317?23.
    [28]
    Padalino MA, Basso C, Milanesi O, Vida VL, Moreolo GS, Thiene G, Stellin G. Surgically treated primary cardiac tumors in early infancy and childhood. J Thorac Cardiovasc Surg. 2005;129:1358?63.
    [29]
    Nir A, Tajik J, Freeman WK, et al. Tuberous sclerosis and cardiac rhabdomyoma. Am J Cardiol. 1995;76:419?21.
    [30]
    Kurian KK, Weisshaar D, Parekh H et al. Primary angiosarcoma: case report and review of the literature. Cardiovascular Pathology, 2006;15:110?2
    [31]
    Thiene G, Valente M, Lombardi M, Basso C. Tumours of the Heart. In: Camm JA, Luscher TF, Serruys PV, eds. ESC Textbook of Cardiovascular Medicine. Oxford: University Press; 2009.
    [32]
    Van Veer H, Meuris B, Verbeken E, Herijgers P. Primary atrial fibrosarcoma of the heart. Cardiovasc Pathol. 2008;17:325?8.
    [33]
    Basso C, Stefani A, Calabrese F, Fasoli G, Valente M. Primary atrial fibrosarcoma diagnosed by endocardial biopsy. Am Heart J. 1996;131:399? 402.
    [34]
    Mazzola A, Spano JP, Valente M, Gregorini R, Villani C, Di Eusanio M, et al. Leiomyosarcoma of the left atrium mimicking a left atrial myxoma. J Thorac Cardiovasc Surg. 2006;131:224?6.
    [35]
    Mazzucco A, Luciani GB, Bertolini P, Faggian G, Morando G, Ghimenton C. Primary leiomyosarcoma of the pulmonary artery: diagnostic and surgical implications. Ann Thorac Surg. 1994;57:222?5.
    [36]
    Burke AP, Rosada-de Christenson ML, Templeton PA, Virmani R. Cardiac fibroma: clinicopathologic correlates and surgical treatment. J Thorac Cardiovasc Surg. 1994;108:862?70
    [37]
    Warren WH. Malignancies involving the pericardium. Semin Thorac Cardiovasc Surg. 2000;12:119?29.
    [38]
    Luk A, Ahn E, Vaideeswar P, Butany JW. Pericardial tumors. Semin Diagn Pathol. 2008;25:47?53.
    [39]
    Bendek M, Ferenc M, Freudenberg N. Post-irradiation pericardial malignant mesothelioma: an autopsy case and review of the literature. Cardiovasc Pathol. 2010;19:377?9.
    [40]
    Yoshiyuki Yamashita, Kazuhiro Kurisu, Satoshi Kimura, and Yasutaka Ueno. Successful resection of a huge metastatic liposarcoma in the pericardium resulting in improvement of diastolic heart failure: a case report. Surg Case Rep. 2015 Dec; 1: 74. Published online 2015 Sep 2. doi: 10.1186/s40792-015-0079-4
    [41]
    Conklin LD, Reardon MJ. Autotransplantation of the heart for primary cardiac malignancy: development and surgical technique. Texas Heart Institute Journal. 2002;29(2):105.
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2015, 2(1), 39-45. http://doi.org/10.31586/Surgery.0201.05
    27 Views 232 Downloads PDF Full-text (584.953 KB)  HTML Full-text
    Abstract
    Objective: To evaluate the relationship between operative approach, operative time, and SSI rate. Methods: Inpatient database review identified patients undergoing 5 common procedures from 1/2010-12/2011. Patients were stratified into laparoscopic or open approaches. The main outcome measure was the relationship between operative time and SSI by approach. Results: 226,006 patients
    [...] Read more.
    Objective: To evaluate the relationship between operative approach, operative time, and SSI rate. Methods: Inpatient database review identified patients undergoing 5 common procedures from 1/2010-12/2011. Patients were stratified into laparoscopic or open approaches. The main outcome measure was the relationship between operative time and SSI by approach. Results: 226,006 patients were evaluated- 28.2% open and 71.8% laparoscopic. Mean overall operative time was significantly shorter laparoscopically (p<0.001). Laparoscopy was associated with significantly lower costs and shorter length of stay (LOS) overall and for each procedure(p<0.0001). Multivariate analysis found SSI increased directly with operative time: for every 30-minute increase, SSI risk increased by 12%. Operative approach was an independent risk factor for SSI: open surgery increased SSI risk by 78%. A direct relationship between open procedures, operative time, and SSI risk was found. Conclusions: Laparoscopy has overall shorter operative time and improved outcomes in SSI rate, LOS, and total costs for common surgical procedures. As operative time and approach were independent risk factors for SSI, the use of laparoscopy and operative time are valuable quality measures.  Full article
    References
    [1]
    Anderson, D. J., Prevention of surgical site infection: beyond SCIP, AORN J, 99, 315, 2014.
    [2]
    Awad, S. S., Adherence to surgical care improvement project measures and post-operative surgical site infections, Surg Infect (Larchmt), 13, 234, 2012.
    [3]
    Edmiston, C. E. et al., Reducing the risk of surgical site infections: did we really think SCIP was going to lead us to the promised land?, Surg Infect (Larchmt), 12, 169, 2011.
    [4]
    Hedrick, T. L., Turrentine, F. E., Smith, R. L., McElearney, S. T., Evans, H. L., Pruett, T. L., and Sawyer, R. G., Single-institutional experience with the surgical infection prevention project in intra-abdominal surgery, Surg Infect (Larchmt), 8, 425, 2007.
    [5]
    Larochelle, M., Hyman, N., Gruppi, L., and Osler, T., Diminishing surgical site infections after colorectal surgery with surgical care improvement project: is it time to move on?, Dis Colon Rectum, 54, 394, 2011.
    [6]
    Leaper, D. J., Tanner, J., Kiernan, M., Assadian, O., and Edmiston, C. E. J., Surgical site infection: poor compliance with guidelines and care bundles, Int Wound J, 2014.
    [7]
    Wick, E. C. et al., Implementation of a surgical comprehensive unit-based safety program to reduce surgical site infections, J Am Coll Surg, 215, 193, 2012.
    [8]
    Klevens, R. M., Edwards, J. R., Richards, C. L. J., Horan, T. C., Gaynes, R. P., Pollock, D. A., and Cardo, D. M., Estimating health care-associated infections and deaths in U.S. hospitals, 2002, Public Health Rep, 122, 160, 2007.
    [9]
    Kirkland, K. B., Briggs, J. P., Trivette, S. L., Wilkinson, W. E., and Sexton, D. J., The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs, Infect Control Hosp Epidemiol, 20, 725, 1999.
    [10]
    Hawkins, R. B. et al., Beyond surgical care improvement program compliance: antibiotic prophylaxis implementation gaps, Am J Surg, 206, 451, 2013.
    [11]
    Surgical Care Improvement Project, Available online at: http://wwwjointcommissionorg/surgical_care_improvement_project/, Accessed June 2014.
    [12]
    Levy, S. M., Phatak, U. R., Tsao, K., Wray, C. J., Millas, S. G., Lally, K. P., and Kao, L. S., What is the quality of reporting of studies of interventions to increase compliance with antibiotic prophylaxis?, J Am Coll Surg, 217, 770, 2013.
    [13]
    Bonjer, H. J. et al., Laparoscopically assisted vs open colectomy for colon cancer: a meta-analysis, Arch Surg, 142, 298, 2007.
    [14]
    Delaney, C. P., Kiran, R. P., Senagore, A. J., Brady, K., and Fazio, V. W., Case-matched comparison of clinical and financial outcome after laparoscopic or open colorectal surgery, Ann Surg, 238, 67, 2003.
    [15]
    Delaney, C. P., Chang, E., Senagore, A. J., and Broder, M., Clinical outcomes and resource utilization associated with laparoscopic and open colectomy using a large national database, Ann Surg, 247, 819, 2008.
    [16]
    Nguyen, N. T., Goldman, C., Rosenquist, C. J., Arango, A., Cole, C. J., Lee, S. J., and Wolfe, B. M., Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs, Ann Surg, 234, 279, 2001.
    [17]
    Schwenk, W., Haase, O., Neudecker, J., and Muller, J. M., Short term benefits for laparoscopic colorectal resection, Cochrane Database Syst Rev, CD003145, 2005.
    [18]
    Veldkamp, R. et al., Laparoscopic surgery versus open surgery for colon cancer: short-term outcomes of a randomised trial, Lancet Oncol, 6, 477, 2005.
    [19]
    Aimaq, R., Akopian, G., and Kaufman, H. S., Surgical site infection rates in laparoscopic versus open colorectal surgery, Am Surg, 77, 1290, 2011.
    [20]
    Poon, J. T., Law, W. L., Wong, I. W., Ching, P. T., Wong, L. M., Fan, J. K., and Lo, O. S., Impact of laparoscopic colorectal resection on surgical site infection, Ann Surg, 249, 77, 2009.
    [21]
    Earle, D., Seymour, N., Fellinger, E., and Perez, A., Laparoscopic versus open incisional hernia repair: a single-institution analysis of hospital resource utilization for 884 consecutive cases, Surg Endosc, 20, 71, 2006.
    [22]
    Bailey, M. B., Davenport, D. L., Vargas, H. D., Evers, B. M., and McKenzie, S. P., Longer operative time: deterioration of clinical outcomes of laparoscopic colectomy versus open colectomy, Dis Colon Rectum, 57, 616, 2014.
    [23]
    Keller, D. S., Khorgami, Z., Swendseid, B., Khan, S., and Delaney, C. P., Identifying causes for high readmission rates after stoma reversal, Surg Endosc, 2013.
    [24]
    Kelly, K. N., Iannuzzi, J. C., Rickles, A. S., Monson, J. R., and Fleming, F. J., Risk Factors Associated with 30-Day Postoperative Readmissions in Major Gastrointestinal Resections, J Gastrointest Surg, 2013.
    [25]
    Bennett, C. L., Stryker, S. J., Ferreira, M. R., Adams, J., and Beart, R. W. J., The learning curve for laparoscopic colorectal surgery. Preliminary results from a prospective analysis of 1194 laparoscopic-assisted colectomies, Arch Surg, 132, 41, 1997.
    [26]
    Miskovic, D., Ni, M., Wyles, S. M., Tekkis, P., and Hanna, G. B., Learning curve and case selection in laparoscopic colorectal surgery: systematic review and international multicenter analysis of 4852 cases, Dis Colon Rectum, 55, 1300, 2012.
    [27]
    Park, J. S., Kang, S. B., Kim, S. W., and Cheon, G. N., Economics and the laparoscopic surgery learning curve: comparison with open surgery for rectosigmoid cancer, World J Surg, 31, 1827, 2007.
    [28]
    Shin, R. B., Evaluation of the learning curve for laparoscopic Roux-en-Y gastric bypass surgery, Surg Obes Relat Dis, 1, 91, 2005.
    [29]
    Garcia, N., Fogel, S., Baker, C., Remine, S., and Jones, J., Should compliance with the Surgical Care Improvement Project (SCIP) process measures determine Medicare and Medicaid reimbursement rates?, Am Surg, 78, 653, 2012.
    [30]
    Kao, L. S., Ghaferi, A. A., Ko, C. Y., and Dimick, J. B., Reliability of superficial surgical site infections as a hospital quality measure, J Am Coll Surg, 213, 231, 2011.
    [31]
    de Lissovoy, G., Fraeman, K., Hutchins, V., Murphy, D., Song, D., and Vaughn, B. B., Surgical site infection: incidence and impact on hospital utilization and treatment costs, Am J Infect Control, 37, 387, 2009.
    [32]
    Dua, A., Aziz, A., Desai, S. S., McMaster, J., and Kuy, S., National Trends in the Adoption of Laparoscopic Cholecystectomy over 7 Years in the United States and Impact of Laparoscopic Approaches Stratified by Age, Minim Invasive Surg, 2014, 635461, 2014.
    [33]
    Minutolo, V., Licciardello, A., Di Stefano, B., Arena, M., Arena, G., and Antonacci, V., Outcomes and cost analysis of laparoscopic versus open appendectomy for treatment of acute appendicitis: 4-years experience in a district hospital, BMC Surg, 14, 14, 2014.
    [34]
    Senagore, A. J., Duepree, H. J., Delaney, C. P., Dissanaike, S., Brady, K. M., and Fazio, V. W., Cost structure of laparoscopic and open sigmoid colectomy for diverticular disease: similarities and differences, Dis Colon Rectum, 45, 485, 2002.
    [35]
    Senagore, A. J., Brannigan, A., Kiran, R. P., Brady, K., and Delaney, C. P., Diagnosis-related group assignment in laparoscopic and open colectomy: financial implications for payer and provider, Dis Colon Rectum, 48, 1016, 2005.
    [36]
    Anaya, D. A. et al., Development and validation of a novel stratification tool for identifying cancer patients at increased risk of surgical site infection, Ann Surg, 255, 134, 2012.
    [37]
    Fahrner, R., Malinka, T., Klasen, J., Candinas, D., and Beldi, G., Additional surgical procedure is a risk factor for surgical site infections after laparoscopic cholecystectomy, Langenbecks Arch Surg, 399, 595, 2014.
    [38]
    Kurmann, A., Vorburger, S. A., Candinas, D., and Beldi, G., Operation time and body mass index are significant risk factors for surgical site infection in laparoscopic sigmoid resection: a multicenter study, Surg Endosc, 25, 3531, 2011.
    [39]
    Schlachta, C. M., Mamazza, J., Seshadri, P. A., Cadeddu, M., Gregoire, R., and Poulin, E. C., Defining a learning curve for laparoscopic colorectal resections, Dis Colon Rectum, 44, 217, 2001.
    [40]
    Simons, A. J., Anthone, G. J., Ortega, A. E., Franklin, M., Fleshman, J., Geis, W. P., and Beart, R. W. J., Laparoscopic-assisted colectomy learning curve, Dis Colon Rectum, 38, 600, 1995.
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2015, 2(2), 73-75. http://doi.org/10.31586/Surgery.0202.04
    30 Views 52 Downloads PDF Full-text (577.100 KB)  HTML Full-text
    Abstract
    The aneurysm is a complex phenomenon which is affected by different factors, such as the biological diseases and the blood flow parameters. The wall shear stress and pressure are the main factors in the establishment and growth of cerebral aneurysm. The circle of Willis is a prevalent location for aneurysm.
    [...] Read more.
    The aneurysm is a complex phenomenon which is affected by different factors, such as the biological diseases and the blood flow parameters. The wall shear stress and pressure are the main factors in the establishment and growth of cerebral aneurysm. The circle of Willis is a prevalent location for aneurysm. On the other hand, the anomalies of circle of Willis cause variations in flow field pattern and also the wall shear stress and pressure. In the present study, the effects of some anomalies in the flow pattern are investigated using three dimensional simulation of the Circle of Willis. The simulations are conducted using commercial ANSYS FLUENT. The obtained results show the major anomalies cause increase wall shear stress and pressure on the wall of circle of Willis. This factor can lead to increase the risk of aneurysm.  Full article
    Figures

    Figure 5 of 5

    References
    [1]
    Gasparotti, R., & Liserre, R. (2005). Intracranial aneurysms. European radiology, 15(3), 441-447.
    [2]
    Papaioannou, T. G., & Stefanadis, C. (2005). Vascular wall shear stress: basic principles and methods. Hellenic J Cardiol, 46(1), 9-15.
    [3]
    Ghodsi, S. R., Esfahanian, V., Shamsodini, R., Ghodsi, S. M., & Ahmadi, G. (2013).Blood flow vectoring control in aortic arch using full and partial clamps.Computers in biology and medicine, 43(9), 1134-1141.
    [4]
    Lasheras, J. C. (2007). The biomechanics of arterial aneurysms. Annu. Rev. Fluid Mech., 39, 293-319.
    [5]
    Kayembe, K. N., Sasahara, M., & Hazama, F. (1984). Cerebral aneurysms and variations in the circle of Willis. Stroke, 15(5), 846-850.
    [6]
    Lazzaro, M. A., Ouyang, B., & Chen, M. (2011). The role of circle of Willis anomalies in cerebral aneurysm rupture. Journal of neurointerventional surgery, 4(1), 22-26.
    [7]
    Papantchev, V., Hristov, S., Todorova, D., Naydenov, E., Paloff, A., Nikolov, D., & Ovtscharoff, W. (2007). Some variations of the circle of Willis, important for cerebral protection in aortic surgery?a study in Eastern Europeans. European journal of cardio-thoracic surgery, 31(6), 982-989.
    [8]
    Eftekhar, B., Dadmehr, M., Ansari, S., Ghodsi, M., Nazparvar, B., & Ketabchi, E. (2006). Are the distributions of variations of circle of Willis different in different populations??Results of an anatomical study and review of literature.BMC neurology, 6(1), 22.
    [9]
    Osborn, A. G. (1999). Diagnostic cerebral angiography. Lippincott Williams & Wilkins.
    [10]
    Ghodsi, S. R., Esfahanian, V., & Ghodsi, S. M. (2014). Modeling Requirements for Computer Simulation of Cerebral Aneurysm. Journal of Computational Medicine, Volume 2014, Article ID 653845, 9 pages.
    [11]
    Ford, M. D., Alperin, N., Lee, S. H., Holdsworth, D. W., & Steinman, D. A. (2005). Characterization of volumetric flow rate waveforms in the normal internal carotid and vertebral arteries. Physiological measurement, 26(4), 477.
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2018, 3(3), 116-119. http://doi.org/10.31586/Surgery.0303.02
    112 Views 80 Downloads 1 Shares PDF Full-text (777.326 KB)  HTML Full-text
    Abstract
    Introduction: Traumatic pulmonary parenchymal cavitary lesions (TPPCs) are pulmonary pseudocysts raiding secondary to lung contusion. Method: To provide an overview of the etiology, presentation, diagnosis and treatment of TPPCs, and to discuss this in the context of a cohort of 12 retrospectively reviewed patients with TPPCs presenting to Sahlgrenska University
    [...] Read more.
    Introduction: Traumatic pulmonary parenchymal cavitary lesions (TPPCs) are pulmonary pseudocysts raiding secondary to lung contusion. Method: To provide an overview of the etiology, presentation, diagnosis and treatment of TPPCs, and to discuss this in the context of a cohort of 12 retrospectively reviewed patients with TPPCs presenting to Sahlgrenska University Hospital, Gothenburg, Sweden, from January 2014 to December 2016. Between January 2014 and December 2016, a total of twelve trauma patients presented to Sahlgrenska University Hospital with TPPC following blunt trauma.Results: TPPCs are of limited clinical consequence. Inexperienced clinicians may treat these inappropriately. A Computed Tomography (CT) scan is the investigation of choice. Treatment is symptomatic. Intervention is indicated only in case of complications.  Full article
    Figures

    Figure 1 of 2

    References
    [1]
    Kaplan LJ, Trooskin SZ, Santora TA, Weiss JP. Percutaneous drainage of recurrent pneumothoraces and pneumatoceles. J Trauma 1996;41:1069?1072.
    [2]
    Costa AN, Giassi KS, Bachion GH, Apanavicius A, Musolino RS, Kairalla RA. Post-traumatic pulmonary pseudocyst in a soccer player: a case report. Radiol Bras. 2013 Mar/Abr;46(2):122?124.
    [3]
    Fagkrezos D, Giannila M, Maniatis P, et al. Posttraumatic pulmonary pseudocyst with hemopneumothorax following blunt chest trauma: a case report. J Med Case Rep. 2012;6:356.
    [4]
    Yazkan R, Ozpolat B, Sahinalp S. Diagnosis and management of post-traumatic pulmonary pseudocyst. Respir Care 2009;54:538-41.
    [5]
    Stathopoulos G, Chrysikopoulou E, Kalogeromitros A, Papakonstantinou K, Poulakis N, Polyzogopoulos D, et al. Bilateral traumatic pulmonary pseudocysts: case report and literature review. J Trauma 2002;53:993-6.
    [6]
    Melloni G, Cremona G, Ciriaco P, Pansera M, Carretta A, Negri G, et al. Diagnosis and treatment of traumatic pulmonary pseudocysts. J Trauma 2003;54:737-43.
    [7]
    Tsitouridis I, Tsinoglou K, Tsandiridis C, Papastergiou C, Bintoudi A. Traumatic pulmonary pseudocysts: CT findings. J Thorac Imaging 2007;22:247-51.
    [8]
    Athanassiadi K, Gerazounis M, Kalantzi N, Kazakidis P, Fakou A, Kourousis D. Primary traumatic pulmonary pseudocysts: a rare entity. Eur J Cardiothorac Surg 2003;23:43-5
    [9]
    Saito A, Yagi N, Nakagawa S, Iinuma Y, Miura K, Takano Y. Lobectomy for traumatic pulmonary pseudocysts with disseminated intravascular coagulation: case report. J Trauma 1995;38:364?365.
  • Open Access Case Report
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2018, 3(3), 144-146. http://doi.org/10.31586/Surgery.0303.07
    39 Views 55 Downloads 3 Shares PDF Full-text (710.616 KB)  HTML Full-text
    Abstract
    Central vein stenosis is a rare complication that occurs after central venous port placement. We report a case of chyle withdrawal from a central venous port in a patient receiving chemotherapy for stage IV rectal cancer. Dilated thoracic duct terminal and innominate vein stenosis both were clearly shown in the
    [...] Read more.
    Central vein stenosis is a rare complication that occurs after central venous port placement. We report a case of chyle withdrawal from a central venous port in a patient receiving chemotherapy for stage IV rectal cancer. Dilated thoracic duct terminal and innominate vein stenosis both were clearly shown in the angiography results, and innominate vein stenosis was resolved by performing percutaneous transluminal angioplasty.  Full article
    Figures

    Figure 2 of 2

    References
    [1]
    Kao CL, Chang JP. Chyle withdrawal from an implanted port in occult innominate vein stenosis. 2001;78:138-40.
    [2]
    Yildizeli B, Laçin T, Batirel HF, Yüksel M. Complications and management of long-term central venous access catheters and ports. 2004;5:174-178.
    [3]
    Lemmers NW1, Gels ME, Sleijfer DT et al. Complications of venous access ports in 132 patients with disseminated testicular cancer treated with polychemotherapy. J Clin Oncol 1996;14:2916-2922.
    [4]
    Van Veldhuizen PJ, Taylor S. Chylothorax: a complication of a left subclavian vein thrombosis. 1996;19:99-101.
    [5]
    Kurekci E, Kaye R, Koehler M. Chylothorax and chylopericardium with a complication of a central venous catheter. 1998;132:1064-1066.
    [6]
    Wadehra D. Central Vein Stenosis. In: Yevzlin AS, Asif A, Salman L, eds. . Springer New York; 2014:131-142.
    [7]
    Song MG, Seo TS, Kang EY, Yong HS, Seo JH, Choi YY. Innominate vein stenosis in breast cancer patients after totally implantable venous access port placement. 2015;16:315-320. doi: 10.5301/jva.5000387.
    [8]
    Puel V, Caudry M, Le Métayer P et al. Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports. 1993;72:2248-2252.
  • Open Access Case Report
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2018, 3(4), 147-150. http://doi.org/10.31586/Surgery.0304.01
    31 Views 71 Downloads PDF Full-text (621.647 KB)  HTML Full-text
    Abstract
    Central venous devices are routinely used in delivering chemotherapy and total parenteral nutrition. Spontaneous migration of central venous catheters is a very rare complication, but the etiology of this problem is not clear. We report here a case of migration of a port catheter to the anterior mediastinum in
    [...] Read more.
    Central venous devices are routinely used in delivering chemotherapy and total parenteral nutrition. Spontaneous migration of central venous catheters is a very rare complication, but the etiology of this problem is not clear. We report here a case of migration of a port catheter to the anterior mediastinum in a patient with stage IVC nasopharyngeal cancer during chemotherapy. The patient presented with pulmonary manifestations in form of shortness of breath and chest tightness caused by left massive pleural effusion. The pleural effusion was resolved by thoracocentesis and the migrated catheter was retrieved surgically.  Full article
    Figures

    Figure 2 of 3

    References
    [1]
    MC Lin, TK Chang, YC Fu, SL Jan. A magic port-A-cath. JACC Cardiovasc Interv 2013;6:e17-e18
    [2]
    RP Doley, P Brar, S Chaudhary, R Bedi, AC Swami, JD Wig. Port catheter fracture and migration in internal jugular vein. Am J Case Rep2012; 13: 14-16.
    [3]
    WC Fan, CH Wu, MJ Tsai, YM Tsai, HL Chang, JY Hung, PH Chen, CJ Yang. Risk factors for venous port migration in a single institute in Taiwan. World J Surg Oncol 2014;12:15.
    [4]
    M Shah, S Patni, R Bagarahatta. Spontaneous chemoport fracture and cardiac migration. Indian J Surg Oncol 2014;5:325-326. doi:10.1007/s13193-014-0353-0.
    [5]
    BL Houston, M Yan. Spontaneous migration of an implanted central venous access device into the ipsilateral jugular vein. CMAJ2016;188:752.
    [6]
    KS Ahn, K Yoo, IH Cha, TS Seo. Spontaneously migrated tip of animplantable port catheter into theaxillary vein in a patient with severecough and the subsequent intervention to reposition It. Korean J Radiol 2008;9(Suppl):81-84. doi:10.3348/kjr.2008.9.s.s81
    [7]
    M Shariat, M Zahiah, PK Chan. Migration of the tip of a central venouscatheter. Iran J Radiol 2008;5:239-243.
    [8]
    CJ Thomas, CS Butler. Delayed pneumothorax and hydrothorax withcentral venous catheter migration. Anaesthesia 1999;54:987-990.
    [9]
    SN Nagel, UK Teichgraber, S Kausche, A Lehmann. Satisfaction and qualityof life: a survey-based assessment in patients with a totally implantablevenous port system. Eur J Cancer Care (Engl) 2012;21:197-204.
    [10]
    CY Wu, JY Fu, PH Feng, YH Liu, CF Wu, TC Kao, SY Yu, PJ Ko, HC Hsieh. Risk factors andpossible mechanisms of intravenous port catheter migration. Eur J VascEndovasc Surg 2012;44:82-87.
    [11]
    HJ Kock, M Pietsch, U Krause, H Wilke, FW Eigler. Implantable vascularaccess systems: experience in 1,500 patients with totally implantedcentral venous port systems. World J Surg 1998;22:12-16.
    [12]
    SL Yeste, JM Galbis Caravajal, CA Fuster Diana, EE Moledo. Protocol for theimplantation of a venous access device (Port-A-Cath system): thecomplications and solutions found in 560 cases. Clin Transl Oncol 2006;8:735-741.
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2019, 4(1), 9-13. http://doi.org/10.31586/CriticalCare.0401.02
    13 Views 51 Downloads PDF Full-text (654.248 KB) PDF Full-text (654.091 KB)  HTML Full-text
    Abstract
    Introduction: Acute hyperthermia is a common complication in the first 24 hours after open heart surgery with the incidence of 12% to 73%. The aim of this study was to evaluate the efficiency of postoperative peritoneal dialysis for controlling acute hyperthermia in pediatrics undergoing on-pump heart surgery. Methods:
    [...] Read more.
    Introduction: Acute hyperthermia is a common complication in the first 24 hours after open heart surgery with the incidence of 12% to 73%. The aim of this study was to evaluate the efficiency of postoperative peritoneal dialysis for controlling acute hyperthermia in pediatrics undergoing on-pump heart surgery. Methods: We reviewed clinical outcomes of 40 infants who underwent congenital surgery from August 2016 to August 2017. Patients were divided into two groups in terms of peritoneal dialysis requirement as group A and B. Demographic data, intraoperative and postoperative variables were compared between the patients. Results: Among the 40 high risk infants who underwent cardiac surgery, 20 patients were treated with peritoneal dialysis (group A). Mean rectal temperature and incidence of acute hyperthermia in 24h after surgery were higher in group A compared to group B (p ˂ 0.05). Infants in group A were younger, lighter and showed lower BSA compare to group B (p < 0.05). Also, higher concentration of serum potassium and lower urinary output were seen in group A compared to group B (p = 0.05). The incidence of neurological events was significantly higher in patients of group A (p < 0.05). Intubation time and intensive care unit stay was significantly more prolonged in the group A with peritoneal dialysis (p ˂ 0.05). Conclusion: Peritoneal dialysis performance was effective in treatment of induced hyperthermia in the first 24 h after operation. Indeed, younger age and lighter weight children are more prone to postoperative complication related to cardiopulmonary bypass surgery.  Full article
    Figures

    Figure 1 of 1

    References
    [1]
    Baskin E, et al. Acute renal failure and mortality after open-heart surgery in infants. Ren Fail. 2005; 27(5):557-560.
    [2]
    Carvalho MV, Maluf MA, Catani R, La Rotta CA, Gomes WJ, Salomao R, et al, Cytokines and pediatric open heart surgery with cardiopulmonary bypass. Cardiol Young. 2001;11(1):36-43.
    [3]
    Seghaye MC, Grabitz RG, Duchateau J, Busse S, Dabritz S, KochD, et al.Inflammatory reaction and capillary leak syndrome related to cardiopulmonary bypass inneonates undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996;112(3):687-697.
    [4]
    Alkan T, et al. Postoperative prophylactic peritoneal dialysis in neonates and infants aftercomplex congenital cardiac surgery. ASAIO J. 2006; 52(6):693-697.
    [5]
    Stratman RC, Flynn JD, Hatton KW. Malignant hyperthermia: a pharmacogeneticDisorder. Orthopedics. 2009;32(11):
    [6]
    Metterlein T, Zink W, Kranke E, Haneya A, Graf B, Kranke P. Cardiopulmonarybypass in malignant hyperthermia susceptible patients: a systematic review of published cases. J Thorac Cardiovasc Surg. 2011;141(6):1488-1495.
    [7]
    Villasis-Keever MA, Zapata-Arenas DM, Penagos-Paniagua MJ.Frequency of postoperative fever in children with congenital heart disease undergoing cardiovascular surgery and associated risk factors. Rev Esp Cardiol. 2002;55(10):1063-1069.
    [8]
    Gupta AK, Singh VK, Varma A. Approach to postoperative fever in pediatric cardiac Patients. Ann Pediatr Cardiol. 2012;5(1):61-68.
    [9]
    Clark JA, Bar-Yosef S, Anderson A, Newman MF, Landolfo K, Grocott HP. Postoperative hyperthermia following off-pump versus on-pump coronary artery bypass Surgery. J Cardiothorac Vasc Anesth. 2005;19(4):426-429.
    [10]
    Thong WY, Strickler AG, Li S, Stewart EE, Collier CL, Vaughn WK, et al. Hyperthermia in the forty-eight hours after cardiopulmonary bypass. Anesth Analg. 2002;95(6):1489-1495.
    [11]
    Chan KL, et al. Peritoneal dialysis after surgery for congenital heart disease in infants and young children. Ann Thorac Surg. 2003; 76(5):1443-1449.
    [12]
    Bynum G, Patton J, Bowers W, Leav I, Hamlet M, Marsili M, et al. Peritoneal lavage cooling in an anesthetized dog heatstroke model. Aviat Space Environ Med. 1978;49(6):779-784.
    [13]
    Laffey JG, Boylan JF, Cheng DC. The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology. 2002;97(1):215-252.
    [14]
    Boigner H, et al. Predictors of mortality at initiation of peritoneal dialysis in children after cardiac surgery. Ann Thorac Surg. 2004;77(1):61-65.
  • Open Access Research Article
    Export citation: APA   BibTeX   EndNote   RIS  
    Trends Journal of Sciences Research 2019, 4(3), 106-110. http://doi.org/10.31586/Cancers.0403.03
    44 Views 69 Downloads PDF Full-text (689.500 KB)  HTML Full-text
    Abstract
    Objective: This study aimed to determine whether perioperative antiviral treatment is facilitate for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and Child-Pugh grade A cirrhosis in perioperative recovery of liver function and HBV activation. Methods: The study included 115 patients with HBV-related HCC and Child-Pugh grade A cirrhosis
    [...] Read more.
    Objective: This study aimed to determine whether perioperative antiviral treatment is facilitate for patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) and Child-Pugh grade A cirrhosis in perioperative recovery of liver function and HBV activation. Methods: The study included 115 patients with HBV-related HCC and Child-Pugh grade A cirrhosis who underwent resection. Patients were prospectively assigned to a preoperative antiviral treatment group (n = 51) or postoperative antiviral treatment group (n = 52); twelve patients who had not received antiviral treatment before and after surgery were designated a non-treatment group (n = 12). HBV reactivation during a month after the operation was defined as a HBV DNA value tenfold over preoperative values. Postoperative liver dysfunction was defined as prothrombin activity <50% and serum bilirubin >50 mmol/L on postoperative day 5. Results: Postoperatively, liver dysfunction was present in 1 of 51 (1.96%) patients who received preoperative antiviral therapy, 1 of 52 (1.92%) who received postoperative therapy, and 3 of 12 (25%) who received no antiviral therapy. HBV reactivation postoperatively occurred at similar rates. Conclusions: Preoperative and postoperative antiviral treatment of patients with Child-Pugh grade A cirrhosis and high levels of HBV DNA undergoing hepatic resection for HCC are both facilitate in preventing perioperative liver dysfunction and reactivation of HBV. Thus, in this population with high levels of HBV DNA, perioperative antiviral treatment is important.  Full article
    References
    [1]
    Huang L, Li J, Yan J, Sun J, Zhang X, Wu M, et al. Antiviral therapy decreases viral reactivation in patients with hepatitis B virus-related hepatocellular carcinoma undergoing hepatectomy: a randomized controlled trial. Journal of viral hepatitis. 2013;20(5):336-342.
    [2]
    Kuzuya T, Katano Y, Kumada T, Toyoda H, Nakano I, Hirooka Y, et al. Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2007;22(11):1929-1935.
    [3]
    Piao CY, Fujioka S, Iwasaki Y, Fujio K, Kaneyoshi T, Araki Y, et al. Lamivudine treatment in patients with HBV-related hepatocellular carcinoma--using an untreated, matched control cohort. Acta Med Okayama. 2005;59(5):217-224.
    [4]
    Zhang B, Xu D, Wang R, Zhu P, Mei B, Wei G, et al. Perioperative antiviral therapy improves safety in patients with hepatitis B related HCC following hepatectomy. Int J Surg. 2015;15:1-5.
    [5]
    Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, et al. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Annals of surgery. 2013;257(3):490-505.
    [6]
    Shuqun C, Mengchao W, Han C, Feng S, Jiahe Y, Wenming C, et al. Antiviral therapy using lamivudine and thymosin alpha1 for hepatocellular carcinoma coexisting with chronic hepatitis B infection. Hepatogastroenterology. 2006;53(68):249-252.
    [7]
    Li N, Lai EC, Shi J, Guo WX, Xue J, Huang B, et al. A comparative study of antiviral therapy after resection of hepatocellular carcinoma in the immune-active phase of hepatitis B virus infection. Annals of surgical oncology. 2010;17(1):179-185.
    [8]
    Chuma M, Hige S, Kamiyama T, Meguro T, Nagasaka A, Nakanishi K, et al. The influence of hepatitis B DNA level and antiviral therapy on recurrence after initial curative treatment in patients with hepatocellular carcinoma. Journal of gastroenterology. 2009;44(9):991-999.
    [9]
    Chan AC, Chok KS, Yuen WK, Chan SC, Poon RT, Lo CM, et al. Impact of antiviral therapy on the survival of patients after major hepatectomy for hepatitis B virus-related hepatocellular carcinoma. Arch Surg. 2011;146(6):675-681.
    [10]
    Zhou Y, Zhang Z, Zhao Y, Wu L, Li B. Antiviral therapy decreases recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection: a meta-analysis. World journal of surgery. 2014;38(9):2395-2402.
    [11]
    Sakamoto K, Beppu T, Hayashi H, Nakagawa S, Okabe H, Nitta H, et al. Antiviral therapy and long-term outcome for hepatitis B virus-related hepatocellular carcinoma after curative liver resection in a Japanese cohort. Anticancer Res. 2015;35(3):1647-1655.
    [12]
    Chong CC, Wong GL, Wong VW, Ip PC, Cheung YS, Wong J, et al. Antiviral therapy improves post-hepatectomy survival in patients with hepatitis B virus-related hepatocellular carcinoma: a prospective-retrospective study. Aliment Pharmacol Ther. 2015;41(2):199-208.
    [13]
    Wu CY, Lin JT, Ho HJ, Su CW, Lee TY, Wang SY, et al. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Gastroenterology. 2014;147(1):143-151 e145.
    [14]
    Ke Y, Ma L, You XM, Huang SX, Liang YR, Xiang BD, et al. Antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after radical hepatectomy. Cancer biology & medicine. 2013;10(3):158-164.
    [15]
    Kubo S, Tanaka H, Takemura S, Yamamoto S, Hai S, Ichikawa T, et al. Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus. Hepatology research : the official journal of the Japan Society of Hepatology. 2007;37(2):94-100.
    [16]
    Wei Q, Xu X, Ling Q, Zhou B, Zheng SS. Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2013;12(3):251-255.
    [17]
    Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10(1):1-98.
    [18]
    Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatol Int. 2012;6(3):531-561.
    [19]
    Balzan S, Belghiti J, Farges O, Ogata S, Sauvanet A, Delefosse D, et al. The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Annals of surgery. 2005;242(6):824-828, discussion 828-829.
    [20]
    Dan JQ, Zhang YJ, Huang JT, Chen MS, Gao HJ, Peng ZW, et al. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013;39(8):865-872.
    [21]
    Lee JI, Kim JK, Chang HY, Lee JW, Kim JM, Chung HJ, et al. Impact of postoperative hepatitis B virus reactivation in hepatocellular carcinoma patients who formerly had naturally suppressed virus. Journal of gastroenterology and hepatology. 2014;29(5):1019-1027.
    [22]
    Huang L, Li J, Lau WY, Yan J, Zhou F, Liu C, et al. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. Journal of gastroenterology and hepatology. 2012;27(1):158-164.
    [23]
    Wang JP, Kao FY, Wu CY, Hung YP, Chao Y, Chou YJ, et al. Nucleos(t)ide analogues associated with a reduced risk of hepatocellular carcinoma in hepatitis B patients: a population-based cohort study. Cancer. 2015;121(9):1446-1455.
    [24]
    Xia BW, Zhang YC, Wang J, Ding FH, He XD. Efficacy of antiviral therapy with nucleotide/nucleoside analogs after curative treatment for patients with hepatitis B virus-related hepatocellular carcinoma: A systematic review and meta-analysis. Clinics and research in hepatology and gastroenterology. 2015; 39(4):458-68.
Filter options
Publication Date
From to
Refine Publication Date
Subject Areas
Refine Subjects
Article Types
Refine Article Types
Countries / Territories
Refine Countries / Territories